Clinical Trials Directory

Trials / Completed

CompletedNCT02482792

Norwegian Psychomotor Physiotherapy in Patients With Long-lasting Musculoskeletal Pain.

Norwegian Psychomotor Physiotherapy Versus Cognitive Patient Education and Active Physiotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Tove Dragesund · Academic / Other
Sex
All
Age
18 Years – 67 Years
Healthy volunteers
Accepted

Summary

The aim is to examine the effect of Norwegian Psychomotor Physiotherapy (NPMP) in employees with long-lasting musculoskeletal pain compared to employees receiving Cognitive Patient Education in combination with active individual physiotherapy (COPE-PT) on pain, function, quality of life and sick-leave

Detailed description

The NPMP is based on the assumption that patients with long-lasting problems, physical and/or psychological, may react with general aberrations related to posture, respiration, and movements, as well as with muscular tension and skin changes. Employees With Long lasting musculoskeletal pain problems, working in the Municipality of Bergen, will be invited to participate in an Randomized Clinical Trial (RCT), and randomized to either receive Norwegian Psychomotor Physiotherapy (NPMP) or a series of Cognitive Patient Education in combination with active individual physiotherapy (COPE-PT). The aim is to examine the effect of NPMP compared to those receiving COPE-PT on pain, function, quality of life and sick-leave.

Conditions

Interventions

TypeNameDescription
OTHERNorwegian Psychomotor PhysiotherapyThe recruited patients will after randomization receive either Norwegian Psychomotor Physiotherapy (NPMP) or COPE combined with active individual physiotherapy. In NPMP the treatment is individualized, targeting body-mind awareness through exercise, massage and therapeutic conversation
OTHERCognitive Patient Education and PTThe comparison group will receive a combination of education about how to manage pain (COPE) followed by active individual physiotherapy.

Timeline

Start date
2013-08-01
Primary completion
2017-10-26
Completion
2017-10-26
First posted
2015-06-26
Last updated
2017-10-27

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02482792. Inclusion in this directory is not an endorsement.